Carol A. Gloff
Geen lopende functies
Profiel
Carol A.
Gloff is the founder of Embera NeuroTherapeutics, Inc., which was founded in 2005.
She held the title of VP-Pre-Clinical Development & Regulatory Affairs.
Dr. Gloff also held former positions at Alkermes, Inc. and ImmunoGen, Inc. as Vice President-Regulatory Affairs.
Additionally, she worked at Triton Biosciences, Inc. as Manager-Pharmacokinetics & Toxicology.
Dr. Gloff received her undergraduate degree from the State University of New York at Buffalo and her graduate degree from The University of California, San Francisco.
Eerdere bekende functies van Carol A. Gloff
| Bedrijven | Functie | Einde |
|---|---|---|
| Triton Biosciences, Inc. | Corporate Officer/Principal | - |
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Algemeen Adviseur | - |
| IMMUNOGEN, INC. | Algemeen Adviseur | 24-08-2011 |
Embera NeuroTherapeutics, Inc.
 Embera NeuroTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Embera NeuroTherapeutics, Inc. develops treatments for smoking cessation, cocaine dependence and other addictions. The company was founded by Nicholas Edward Goeders and Marie A. Lindner in 2005 and is headquartered in Sudbury, MA. | Oprichter | - |
Opleiding van Carol A. Gloff
| State University of New York at Buffalo | Undergraduate Degree |
| The University of California, San Francisco | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Alkermes, Inc.
Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Health Technology |
ImmunoGen, Inc.
 ImmunoGen, Inc. BiotechnologyHealth Technology ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151. The company was founded on March 27, 1981 and is headquartered in Waltham, MA. | Health Technology |
Embera NeuroTherapeutics, Inc.
Embera NeuroTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Embera NeuroTherapeutics, Inc. develops treatments for smoking cessation, cocaine dependence and other addictions. The company was founded by Nicholas Edward Goeders and Marie A. Lindner in 2005 and is headquartered in Sudbury, MA. | Health Technology |
| Triton Biosciences, Inc. |
